We investigated the influence of individual-difference variables implicated as risk factors for
Alzheimer's disease (AD) or known to be related to cognitive performance in normal aging …

Abstract Background.—Although Alzheimer's disease (AD) is a progressive degenerative
condition, there is great intra-and inter-individual variability in rates of cognitive decline …

Alzheimer's disease is characterized by progressive cognitive decline. However, little is
known about the “typical” rate of decline, the degree of individual heterogeneity evident in …

This study investigated the relationship between premorbid and current cognitive function
with respect to the clinical features of patients with various types of neurodegeneration in the …

We examined the pattern of cognitive impairment and rate of cognitive and functional
decline as a function of age at symptom onset in 127 patients with probable Alzheimer's …

Better knowledge of the preclinical phase of Alzheimer's disease would be an important
advance to allow earlier treatment of this ominous disease. This prodromal period was …

Background: Cognitive changes during the preclinical phase of Alzheimer's disease (AD)
dementia have been characterized among European Americans (EAs), but studies of …

Background High β-amyloid (Aβ) is associated with faster memory decline in healthy
individuals and adults with mild cognitive impairment (MCI). However, longer prospective …

Although neuropathologic studies showed that early-onset Alzheimer's disease (EAD) and
“senile dementia” were indistinguishable, clinical studies suggested that EAD and late-onset …

The aim of this study was to evaluate the accuracy of neuropsychological assessment in
predicting conversion from subjective cognitive decline (SCD) and mild cognitive impairment …